Início › Obesidade › Arizona

Ensaios clínicos de Obesidade em Arizona

40 estudos para Obesidade estão buscando participantes em locais em Arizona.

Cidades em Arizona

Texto oficial do estudo (Inglês)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Headlands Research - Scottsdale /ID# 282571, Scottsdale

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Pima Heart, Tucson
Eclipse Clinical Research, Tucson

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07783802

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

AMR Clinical, Tempe

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07837973

Early Tracking of Childhood Health Determinants (ETCHED) Study

NIDDK, Phoenix, Phoenix

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

1 Day – 99 Years · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT03481829

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

University of Arizona, Tucson

RecrutandoFase 3

Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Tucson Clinical Research Institute, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RIO Clinical Trials - Phoenix, Phoenix
Headlands Research - Scottsdale, Scottsdale
Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Mesa
Research Site, Phoenix
Research Site, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Synexus Clinical Research US, Inc., Phoenix
Medical Advancement Centers of Arizona, Phoenix

RecrutandoFase 3

Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Headlands Research - Scottsdale, Scottsdale

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Care Access - 801 South Power Road, Mesa, Mesa
Elite Pain and Spine Institute - South Crimson Road, Mesa
Elite Clinical Studies, LLC, Phoenix
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07589608

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

NIDDK, Phoenix, Phoenix

RecrutandoVoluntários saudáveis bem-vindos

Idades de 18 a 99 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06223555

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Phoenix
AURORA-1 Clinical Site, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Peoria
AURORA-2 Clinical Site, Phoenix
AURORA-2 Clinical Site, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

HonorHealth, Phoenix
Medical Advancement Centers of Arizona, Phoenix
Pima Heart and Vascular Clinical Research, Tucson
e mais 1

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Arizona Clinical Trials, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Helios Clinical Research - Phoenix, Phoenix

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Arizona Clinical Trials, Tucson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Chandler
ACCOMPLISH-2 Research Site, Phoenix
ACCOMPLISH-2 Research Site, Sun City West
e mais 1

RecrutandoFase 3Voluntários saudáveis bem-vindos

Idades de 18 a 79 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Dignity Health, Mercy Gilbert, Gilbert

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
Synexus Clinical Research US, Inc., Phoenix
Pima Heart, Tucson

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Medical Dermatology Specialists, Phoenix

RecrutandoFase 4

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Phoenix
Kailera Clinical Site, Sun City

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Sun City

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Gilbert Center for Family Medicine, Gilbert

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera Clinical Site, Glendale
Kailera Clinical Site, Phoenix

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07284979

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NIDDK, Phoenix, Phoenix

RecrutandoVoluntários saudáveis bem-vindos

Idades de 18 a 60 · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT05545306

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Arizona Clinical Trials, Chandler
Epic Medical Research - Sun City, Sun City

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Mesa

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07784725

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Exponent Phoenix, Phoenix

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07776678

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Mercy Gilbert Medical Center, Gilbert
Sun City Clinical Research, Glendale
Honor Health, Phoenix
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Phoenix
ACCOMPLISH-1 Research Site, Sun City West
ACCOMPLISH-1 Research Site, Tucson

RecrutandoFase 3

Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361

Fibrosis Lessens After Metabolic Surgery

Banner Health Center, Phoenix

RecrutandoFase 4Voluntários saudáveis bem-vindos

Idades de 18 a 75 · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06374875

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Arizona Research Center, Inc., Phoenix

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT07481630

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Arizona Liver Health, Chandler
Adobe Clinical Research, Tucson

RecrutandoFase 1/2

Idades de 18 a 65 · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT06836609

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Mayo Clinic in Arizona, Scottsdale

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 30 a 70 · Todos os sexos · Atualizado em 28 de jan. de 2026 · NCT04232566

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

The University of Arizona College of Medicine- Phoenix, Phoenix

RecrutandoFase 3

Idades de 18 a 75 · Todos os sexos · Atualizado em 14 de nov. de 2025 · NCT06499857

A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

PRANDIAL Lab, Flagstaff

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 14 de nov. de 2024 · NCT04755062

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.